Jonathan Hepple

Investor type:

Social media:

Available after registration.

Past investments

  • Aprea
  • MerLion Pharma
  • Modus Therapeutics
  • NovImmune
  • Biosergen AS
  • Asarina Pharma
  • EyeSense AG
  • Dilafor